C. García-Arias

Lipoprotein lipase activity and mass, apolipoprotein C-II mass and polymorphisms of apolipoproteins E and A5 in subjects with prior acute hypertriglyceridaemic pancreatitis

G. Olivecrona, P. González-Sántos, P. Valdivielso, 2009, BMC gastroenterology.

Short-Term Effect of Various Doses of Cyclosporin A on Plasma Lipoproteins and its Distribution in Blood: An Experimental Study

R. Andrade, M. Lucena, J. González-Correa, 1993, Human & experimental toxicology.

Association between hepatitis C virus seroreactivity and HIV infection in non-intravenous drug abusing prostitutes

J. Pineda, A. Vergara, J. Hernández-Quero, 1995, European Journal of Clinical Microbiology and Infectious Diseases.

Predictive factors of achieving therapeutic goals of hypertriglyceridemia

N. Plana, J. Mostaza, A. Hernández-Mijares, 2014, Current medical research and opinion.

Statins: Hepatic Disease and Hepatotoxicity Risk

R. Andrade, M. Lucena, P. González-Sántos, 2008 .

Omega 3 fatty acids induce a marked reduction of apolipoprotein B48 when added to fluvastatin in patients with type 2 diabetes and mixed hyperlipidemia: a preliminary report

P. González-Sántos, P. Valdivielso, J. Rioja, 2009, Cardiovascular diabetology.

[Clinical features of patients with hypertriglyceridemia referred to lipid units: registry of hypertrigliceridemia of the Spanish Arteriosclerosis Society].

N. Plana, L. Masana, R. Mateo-Gallego, 2011, Medicina clinica.

[Glucagon-like peptide-1 (GLP-1) mimetics: a new treatment for Alzheimer's disease?].

N. García-Casares, R. Gómez-Huelgas, C. García-Arias, 2014, Revista de neurologia.